The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: temozolomide     Quarter: 2016Q3

Total Drug/Injury Combinations: 303     Number of Pages: 16

DRUGNAME PT EventCount
TEMOZOLOMIDE. Disease progression 84 view events
TEMOZOLOMIDE. Herpes zoster 50 view events
TEMOZOLOMIDE. Intracranial tumour haemorrhage 50 view events
TEMOZOLOMIDE. Liver disorder 50 view events
TEMOZOLOMIDE. Neutropenia 31 view events
TEMOZOLOMIDE. Death 29 view events
TEMOZOLOMIDE. Platelet count decreased 26 view events
TEMOZOLOMIDE. Neutrophil count decreased 23 view events
TEMOZOLOMIDE. Leukopenia 22 view events
TEMOZOLOMIDE. Lymphocyte count decreased 22 view events
TEMOZOLOMIDE. Hyperkalaemia 21 view events
TEMOZOLOMIDE. Monocyte count increased 21 view events
TEMOZOLOMIDE. Fatigue 17 view events
TEMOZOLOMIDE. Thrombocytopenia 16 view events
TEMOZOLOMIDE. Anaemia 11 view events
TEMOZOLOMIDE. Disorientation 10 view events
TEMOZOLOMIDE. Herpes simplex encephalitis 10 view events
TEMOZOLOMIDE. Drug ineffective 9 view events
TEMOZOLOMIDE. Confusional state 8 view events
TEMOZOLOMIDE. Bone marrow failure 7 view events

Total Drug/Injury Combinations: 303     Number of Pages: 16

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)